Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 529 of 1,261

  1. US 10149847

    Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

    Lixte Biotechnology, Inc. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  2. US 10149841

    Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof

    Shenyang Sunshine Pharmaceutical Co., LTD · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  3. US 10149836

    Isoxazole treatments for frontotemporal dementia

    The Board of Regents of the University of Texas System · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  4. US 10151763

    Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome

    Corcept Therapeutics Incorporated · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  5. US 10149481

    Arthropod control compositions and methods

    TYRATECH, INC. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  6. US 10149470

    Methods and compositions for vein harvest and autografting

    THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERNS AFFAIRS · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  7. US 10149829

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  8. US 10149853

    Stabilized formulations of CNS compounds

    Supernus Pharmaceuticals, Inc. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  9. US 10150783

    Heterocyclic ITK inhibitors for treating inflammation and cancer

    Aclaris Therapeutics, Inc. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  10. US 10150806

    Aldehyde tags, uses thereof in site-specific protein modification

    The Regents of the University of California · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  11. CA 3065417

    TRAITEMENT DE MALADIES ASSOCIEES A UNE DYSREGULATION DE LA VOIE MTOR

    BIOCODEX [FR] · Granted Dec 6, 2018 · Expires Dec 1, 2038

    granted

  12. US 10144753

    Anthracycline derivatives for treating tumor diseases

    Produkem Molekulares Design GMBH · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  13. US 10143671

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  14. US 10143658

    Multistage delivery of active agents

    The Board of Regents of the University of Texas System · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  15. US 10143219

    Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  16. US 10143695

    Pyrrolobenzodiazepines and conjugates thereof

    Mersana Therapeutics, Inc. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  17. US 10143751

    Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  18. US 10143636

    Porous silica particle and cleansing cosmetic

    JGC Catalysts and Chemicals Ltd. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  19. US 10144767

    Anti-microbial peptides and coatings

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  20. US 10144762

    Antibacterial antisense oligonucleotide and method

    Sarepta Therapeutics, Inc. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  21. US 10144804

    Method for preparing functionalized polymers from polymer alcohols

    Nektar Therapeutics · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  22. US 10144930

    Inhibitors of MYH7B and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  23. US 10144743

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  24. US 10144726

    Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer

    SENTINEL ONCOLOGY LIMITED · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.